The effect of an exon 12 polymorphism of the human thromboxane synthase (CYP5A1) gene in stroke patients

Medical Science Monitor

Volumn 15, Issue 1, 2009, Pages

  Kimouli, Maria ^a   Gourvas, Viktoras ^a   Konstantoudaki, Xanthippi ^a   Basta, Maria ^b   Miyakis, Spiros ^c,d   Spandidos, Demetrios A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b Venizelion General Hospital   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Arachidonic acid; Aspirin; CYP5A1; Single nucleotide polymorphism; Stroke; Thromboxane synthase; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ADENINE; GUANINE; HEME; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THROMBOXANE SYNTHASE;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ENZYME ACTIVE SITE; ENZYME ACTIVITY; EXON; FEMALE; GENETIC POLYMORPHISM; GREECE; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BINDING; RECURRENT DISEASE; SECONDARY PREVENTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STROKE PATIENT; TREATMENT FAILURE; WILD TYPE;

DNA PRIMERS; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; GREECE; HEME; HUMANS; MALE; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; SPECTROPHOTOMETRY, ULTRAVIOLET; STROKE; THROMBOXANE-A SYNTHASE;

EID: 58649083445     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kistler JP: Atherothrombotic cerebrovascular disease - large and small vessels. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996: 1601
2. Caplan LR: Caplan's stroke, a clinical approach. Boston: Butterworth-Heinemann, 2000: 17
3. Hajjar KA, Esmon NL, Marcus AJ, Muller W: Vascular function in hemostasis. In: Beutler E, ed. Williams hematology. New York: McGraw-Hill, 2001: 1451-70
4. Chen ZM, Sandercock P, Pan HC et al: Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke, 2000; 31: 1240-49
5. Moncada S, Vane JR: Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med, 1979; 300: 1142-47
6. Needleman P, Turk J, Jakschik BA et al: Arachidonic acid metabolism. Annu Rev Biochem, 1986; 55: 69-102
7. Nelson DR, Kamataki T, Waxman DJ et al: The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol, 1993; 12: 1-51
8. Mestel F, Oetliker O, Beck E et al: Severe bleeding associated with defective thromboxane synthetase. Lancet, 1980; 1: 157
9. Tazawa R, Green ED, Ohashi K et al: Characterization of the complete genomic structure of human thromboxane synthase gene and functional analysis of its promoter. Arch Biochem Biophys 1996; 334: 349-56
10. Wang LH, Tazawa R, Lang AQ, Wu KK: Alternate splicing of human thromboxane synthase mRNA. Arch Biochem Biophys, 1994; 315: 273-78
11. Chevalier D, Lo-Guidice JM, Sergent E et al: Identification of genetic variants in the human thromboxane synthase gene (CYP5A1). Mutat Res, 2001; 432: 61-67
12. Wang LH, Matijevic-Aleksic N, Hsu PY et al: Identification of thromboxane A2 synthase active site residues by molecular modeling-guided site-directed mutagenesis. J Biol Chem, 1996; 271: 19970-75
13. Bartsch H, Nair U, Risch A et al: Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev, 2000; 9: 3-28
14. Adams HP Jr, Bendixen BH, Kappelle LJ et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993; 24: 35-41
15. De Backer G, Ambrosioni E, Borch-Johnsen K et al: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis, 2004; 173: 381-91
16. Dialyna IA, Miyakis S, Georgatou N, Spandidos DA: Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk. Oncol Rep, 2003; 10: 1829-35
17. Fanning GC, Bunce M, Black CM, Welsh KI: Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens, 1997; 50: 23-31
18. Marez D, Legrand M, Sabbagh N et al: Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics, 1997; 7: 193-202
19. Tanaka E: Update: genetic polymorphism of drug metabolizing enzymes in humans. J Clin Pharm Ther, 1999; 24: 323-29
20. Davis SM, Donnan GA: Why lacunar syndromes are different and important. Stroke, 2004; 35: 1780-81
21. Xia Z, Shen RF, Baek SJ, Tai HH: Expression of two different forms of cDNA for thromboxane synthase in insect cells and site-directed mutagenesis of a critical cysteine residue. Biochem J, 1993; 295 (Pt 2): 457-61